Multimedia

In this video from Psych Congress 2020, Sanjai Rao, MD, discusses whether imaging data could play a role in diagnosing schizophrenia.

Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD).

In this video, Joohi Jimenez‑Shahed, MD, explains a 3-year, open-label study which evaluated the long-term efficacy and safety of deutetrabenazine, a treatment for the movement disorder tardive dyskinesia. 

After 25 years as CEO of Caron Treatment Centers, Doug Tieman announced recently that he plans to retire in June 2021. As he sketches out his next chapter, Tieman joins the BHE Podcast to share thoughts on how his own recovery has shaped his leadership style and management at Caron, why not-for-profits have to balance their mission with their margins, the evolution of measuring treatment outcomes…

In this video, Joseph F. Goldberg, MD, explains the conditions under which lithium may be an effective treatment for patients with bipolar disorder.

In this video, Sanjai Rao, MD, of the University of California San Diego School of Medicine, discusses whether genomic data can aid in the diagnosis of schizophrenia.

Neurodevelopmental pediatrician Frank Lopez, MD, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).

In this video, neuropsychiatrist Theresa Cerulli, MD, addresses the myth that most cases of attention-deficit/hyperactivity disorder (ADHD) are simple to treat.

In this video, Psych Congress 2020 presenter Timothy Wilens, MD, provides strategies clinicians can use when treating a patient with both attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD).

Tina Matthews Hayes, DNP, FNP, PMHNP provides an overview of bipolar disorder, including common symptoms and the value of earning your patient’s trust.